AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast ...

With rapid innovations in biotechnology, companies are developing groundbreaking therapies and diagnostic tools that address ...

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Several of these commercialized cell therapies have emerged as top-selling drugs in the healthcare sector. For example, Gilead Sciences reported that Yescarta achieved sales exceeding USD 1.5 billion, ...

Public health groups raise concern on patent grant to promising, new HIV drug Patient and public health groups have raised concerns over a potential patent grant to Gilead Sciences for the HIV drug ...

A Senate hearing Tuesday will look at why the list prices of Ozempic and Wegovy are much higher in the U.S. than in ...

I hope you found this article useful. Please let me know if you have any ideas for improving the format or data included in this series. Editor's Note: This article discusses one or more securities ...

Global Hepatocyte Growth Factors (HGFs) market is valued at approximately USD 70.3 million in 2023 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2024 ...

Pakistan PM Shehbaz to raise Kashmir, Palestine, Islamophobia issues at UNGA Pakistan Prime Minister Shehbaz Sharif is set to address the United Nations General Assembly on September 27. He will ...

Trump and the Republican National Committee he controls decided to share get-out-the-vote duties in the most competitive states with groups such as the one supported by billionaire Elon Musk.

The iPhone 16 Pro's High-Res Slow Motion Video Is the Best Apple Feature in Years ...